Last update : 08/05/2015 | Version : 3 | ID : 8954
General | |
Identification | |
Detailed name | Longitudinal Study on Diabetic Patients Treated with Detemir Insulin |
Sign or acronym | PREDICTIVE: Predictable Results and Experience in Diabetes through Intensification and Control to Target: An International Variability Evaluation |
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL |
General Aspects | |
Medical area |
Endocrinology and metabolism |
Health determinants |
Genetic |
Keywords | analogue, determir insulin, efficacy, tolerance |
Scientific investigator(s) (Contact) | |
Name of the director | Marre |
Surname | Michel |
Address | Faculté de Médecine Xavier Bichat 16 rue Henri Huchard 75870 Paris Cedex 18 |
Phone | +33 (0)1 44 85 62 28 |
michel.marre@bch.aphp.fr | |
Unit | Unité 695 : Déterminants génétiques du diabète de type 2 et de ses complications vasculaires |
Organization | Inserm |
Collaborations | |
Funding | |
Funding status |
Private |
Details | - Novo Nordisk A/S. |
Governance of the database | |
Sponsor(s) or organisation(s) responsible | Institut National de la Santé et de la Recherche Médicale - Inserm |
Organisation status |
Public |
Additional contact | |
Main features | |
Type of database | |
Type of database |
Study databases |
Study databases (details) |
Longitudinal study (except cohorts) |
Database recruitment is carried out by an intermediary |
A selection of health care professionals |
Database recruitment is is made on the basis of: |
Another treatment or procedure |
Database recruitment is carried out as part of an interventional study |
No |
Additional information regarding sample selection. | At the discretion of the treating physician. |
Database objective | |
Main objective | To investigate the effect of using determir insulin in normal clinical practice. |
Inclusion criteria |
- Male and female;
- Adult; - Diabetic (type 1 and 2); - Treated with determir insulin. |
Population type | |
Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
Population covered |
Sick population |
Gender |
Male Woman |
Geography area |
International |
Detail of the geography area | Europe (Austria, Denmark, France, Germany, Ireland, Turkey, United Kingdom). |
Data collection | |
Dates | |
Date of first collection (YYYY or MM/YYYY) | 2006 |
Size of the database | |
Size of the database (number of individuals) |
[1000-10 000[ individuals |
Details of the number of individuals | 19,911 (Europe): - France (1,772): - 643 patients with type 1 diabetes - 1,129 patients with type 2 diabetes. |
Data | |
Database activity |
Data collection completed |
Type of data collected |
Clinical data Biological data |
Clinical data (detail) |
Direct physical measures |
Details of collected clinical data | -- |
Biological data (detail) | Glycaemic control |
Presence of a biobank |
No |
Health parameters studied |
Health event/morbidity |
Procedures | |
Participant monitoring |
Yes |
Details on monitoring of participants | Visits at baseline, 12 weeks, 26 weeks and 52 weeks. |
Links to administrative sources |
No |
Promotion and access | |
Promotion | |
Link to the document | http://tinyurl.com/Pubmed-PREDICTIVE |
Description | List of publications in Pubmed |
Access | |
Terms of data access (charter for data provision, format of data, availability delay) | Contact the scientist in charge. |
Access to aggregated data |
Access on specific project only |
Access to individual data |
Access on specific project only |
Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05